Oral films: Current status and future perspectives I - Galenical development and quality attributes

JOURNAL OF CONTROLLED RELEASE

卷:206

Review

Borges, Ana Filipa^1,2  Silva, Claudia¹  Coelho, Jorge F. J.³  Simoes, Sergio^1,2 

[1] Bluepharma, Ind Farmaceut SA, Coimbra, Portugal

[2] Univ Coimbra, Fac Pharm, P-3000 Coimbra, Portugal

[3] Univ Coimbra, Fac Sci & Technol, CIEPQPF, P-3000 Coimbra, Portugal

关键词: Oral films;    Film forming polymers;    Market;    Galenical development;   

DOI  :  10.1016/j.jconrel.2015.03.006

来源: Elsevier

【 摘 要 】

Polymers are the most common excipients used in pharmaceutical dosage forms, and often new applications and innovative polymers appear aiming to overcome unmet needs in the drug formulation field. Orodispersible dosage forms based on polymeric matrices have currently demonstrated their prominence in accordance with the actual market requirements and patients' demands. The versatility of the polymeric oral films had proven their high value as suitable technological platforms for extension and adjustment to different delivery routes and promising markets. These are the main reasons for the increasing investment of several companies in this technology and their applicability in different therapeutic segments. This pharmaceutical form with a blustering beginning as a breath freshener had an emergent entrance in the Rx market proving its reliable value. This review describes and explores the oral film technology from its main component, the polymeric matrices, to the new and possible market applications, highlighting all the critical and important points of its development. (C) 2015 Elsevier B.V. All rights reserved.

【 授权许可】

Free